- Investing.com
Metrics to compare | SGIOY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGIOYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.1x | 15.1x | −0.4x | |
PEG Ratio | 0.19 | 0.15 | 0.00 | |
Price/Book | 1.4x | 1.5x | 2.6x | |
Price / LTM Sales | 4.3x | 1.9x | 3.1x | |
Upside (Analyst Target) | 39.1% | 15.0% | 48.3% | |
Fair Value Upside | Unlock | 11.9% | 6.2% | Unlock |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.